Physician profile
Bridget Vera
NPI 1588309397
$371.39
in general payments reported to CMS, 2019-2025
8 companies · $21.28 in 2025
The $21.28 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $49.24 · 2024: $301 · 2025: $21.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $172.51 | 2024 | Aptima, Thinprep 2000 Processor |
| Astrazeneca Pharmaceuticals Lp | $56.43 | 2024 | Airsupra |
| Abbott Laboratories | $38.64 | 2024-2025 | Proclaim, Freestyle Libre |
| Kowa Pharmaceuticals America, INC. | $31.76 | 2023 | Seglentis |
| Exact Sciences Corporation | $18.54 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $18.41 | 2024 | |
| Novo Nordisk INC | $17.62 | 2024 | Rybelsus |
| Amgen INC. | $17.48 | 2023 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Vera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.